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A B S T R A C T
Background: The World Health Organization (WHO) and the International Labour Organization (ILO) are developing a joint methodology for estimating the national
and global work-related burden of disease and injury (WHO/ILO joint methodology), with contributions from a large network of experts. In this paper, we present the
protocol for two systematic reviews of parameters for estimating the number of disability-adjusted life years from osteoarthritis of hip or knee, and selected other
musculoskeletal diseases respectively, attributable to exposure to occupational ergonomic risk factors to inform the development of the WHO/ILO joint methodology.
Objectives: We aim to systematically review studies on exposure to occupational ergonomic risk factors (Systematic Review 1) and systematically review and meta-
analyze estimates of the effect of exposure to occupational ergonomic risk factors on osteoarthritis of the hip or knee, and selected other musculoskeletal diseases
respectively (Systematic Review 2), applying the Navigation Guide systematic review methodology as an organizing framework, conducting both systematic reviews
in tandem and in a harmonized way.
Data sources: Separately for Systematic Reviews 1 and 2, we will search electronic academic databases for potentially relevant records from published and un-
published studies, including Medline, EMBASE, Web of Science and CISDOC. We will also search electronic grey literature databases, Internet search engines and
organizational websites; hand-search reference lists of previous systematic reviews and included study records; and consult additional experts.
Study eligibility and criteria: We will include working-age (≥15 years) workers in the formal and informal economy in any WHO and/or ILO Member State, but
exclude children (< 15 years) and unpaid domestic workers. The included occupational ergonomic risk factors will be any exposure to one or more of: force exertion;
demanding posture; repetitiveness; hand-arm vibration; lifting; kneeling and/or squatting; and climbing. Included outcomes will be (i) osteoarthritis and (ii) other
musculoskeletal diseases (i.e., one or more of: rotator cuff syndrome; bicipital tendinitis; calcific tendinitis; shoulder impingement; bursitis shoulder; epicondylitis
medialis; epicondylitis lateralis; bursitis elbow; bursitis hip; chondromalacia patellae; meniscus disorders; and/or bursitis knee). For Systematic Review 1, we will
include quantitative prevalence studies of any exposure to occupational ergonomic risk factors stratified by country, gender, age and industrial sector or occupation.
For Systematic Review 2, we will include randomized controlled trials, cohort studies, case-control-studies and other non-randomized intervention studies with an
estimate of the relative effect of any exposure with occupational ergonomic risk factors on the prevalence or incidence of osteoarthritis and/or selected muscu-
loskeletal diseases, compared with the theoretical minimum risk exposure level (i.e., no exposure).
Study appraisal and synthesis methods: At least two review authors will independently screen titles and abstracts against the eligibility criteria at a first stage and full
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texts of potentially eligible records at a second stage, followed by extraction of data from qualifying studies. At least two review authors will assess risk of bias and the
quality of evidence, using the most suited tools currently available. For Systematic Review 2, if feasible, we will combine relative risks using meta-analysis. We will
report results using the guidelines for accurate and transparent health estimates reporting (GATHER) for Systematic Review 1 and the preferred reporting items for
systematic reviews and meta-analyses guidelines (PRISMA) for Systematic Review 2.
PROSPERO registration number: CRD42018102631.
1. Background
The World Health Organization (WHO) and the International
Labour Organization (ILO) are developing a joint methodology for es-
timating the work-related burden of disease and injury (WHO/ILO joint
methodology) (Ryder, 2017). The organizations plan to estimate the
numbers of deaths and disability-adjusted life years that are attribu-
table to selected occupational risk factors, in the first place for the year
2015. The WHO/ILO joint methodology will be based on already ex-
isting methodologies of WHO and ILO for estimating the burden of
disease for selected occupational risk factors (Prüss-Ustün et al., 2017;
International Labour Organization, 2014). It will expand existing
methodologies with estimation of the burden of several prioritized
additional pairs of occupational risk factors and health outcomes. For
this purpose, population attributable fractions (Murray et al., 2004) –
the proportional reduction in burden from the health outcome achieved
by a reduction of exposure to the risk factor to zero – will be calculated
for each additional risk factor-outcome pair, and these fractions will be
applied to the total disease burden envelopes for the health outcome
from the WHO Global Health Estimates (World Health Organization,
2017).
The WHO/ILO joint methodology will likely include the existing
and established methodologies for estimating the burdens of low back
and neck pain attributable to occupational ergonomic risk factors. In
addition, it may however also include a methodology for estimating the
burden of osteoarthritis of hip or knee and selected other musculoske-
letal diseases (other than low back pain and neck pain) arising from
exposure to occupational ergonomic risk factors if feasible, as two ad-
ditional prioritized risk factor-outcome pairs. Of all musculoskeletal
diseases other than low back pain and neck pain, the ones we have
selected as “osteoarthritis of hip or knee” and “selected other muscu-
loskeletal diseases” probably accrue the relatively highest occupational
disease burdens. To optimize parameters used in estimation models, a
systematic review is required of studies on the prevalence of exposure
to occupational ergonomic risk factors (‘Systematic Review 1’), as well
as a second systematic review and meta-analysis of studies with esti-
mates of the effect of exposure to occupational ergonomic risk factors
on osteoarthritis of hip or knee, and selected other musculoskeletal
diseases respectively, (‘Systematic Review 2’). In the current paper, we
present the protocol for these two systematic reviews, in parallel to
presenting systematic review protocols on other additional risk factor-
outcome pairs elsewhere (Descatha et al., 2018; Godderis et al., 2018;
Li et al., 2018; Mandrioli et al., 2018; Paulo et al., 2018; Rugulies et al.,
Accepted; Teixeira et al., 2018; Tenkate et al., 2018). To our knowl-
edge, this is the first systematic review protocol of its kind. The WHO/
ILO joint estimation methodology and the burden of disease estimates
are separate from these systematic reviews, and they will be described
and reported elsewhere.
We refer separately to Systematic Reviews 1 and 2, because the two
systematic reviews address different objectives and therefore require
different methodologies. The two systematic reviews will, however, be
harmonized and conducted in tandem. This will ensure that – in the
later development of the methodology for estimating the burden of
disease from this risk factor-outcome pair – the parameters on the risk
factor prevalence are optimally matched with the parameters from
studies on the effect of the risk factor on the designated outcome. The
findings from Systematic Reviews 1 and 2 will be reported in two dis-
tinct journal articles.
1.1. Rationale
To consider the feasibility of estimating the burden of selected
musculoskeletal diseases from exposure to occupational ergonomic risk
factors, and to ensure that potential estimates of burden of disease are
reported in adherence with the guidelines for accurate and transparent
health estimates reporting (GATHER) (Stevens et al., 2016), WHO and
ILO require a systematic review of studies on the prevalence of relevant
levels of exposure to occupational ergonomic risk factors (Systematic
Review 1), as well as a systematic review and a meta-analysis of studies
with estimates of the relative effect of exposure to occupational ergo-
nomic risk factors on the prevalence or incidence of osteoarthritis of hip
or knee, and selected other musculoskeletal diseases respectively,
compared with the theoretical minimum risk exposure level (Systematic
Review 2). The theoretical minimum risk exposure level is the level that
would result in the lowest possible population risk, even if it is not
feasible to attain this exposure level in practice (Murray et al., 2004).
These data and effect estimates should be tailored to serve as para-
meters for estimating the burden of osteoarthritis of hip or knee, and
selected other musculoskeletal diseases respectively, from exposure to
occupational ergonomic risk factors in the WHO/ILO joint metho-
dology.
We are not aware of any previous systematic reviews of the existing
evidence on the exposure to any of the occupational ergonomic risk
factors covered in this review (i.e., one or more of: force exertion, de-
manding posture, repetitiveness, hand-arm vibration, lifting, kneeling
and/or squatting, and climbing) independent of a specific disease
(Systematic Review 1). Seven previous systematic reviews have how-
ever focused on the evidence on the effect of exposure to one or more of
these occupational ergonomic risk factors on one or more selected
musculoskeletal diseases of the shoulder (van Rijn et al., 2010; van der
Molen et al., 2017; Lievense et al., 2001); elbow (Descatha et al., 2016);
hip (Jensen, 2008; Lievense et al., 2001); and knee (Verbeek et al.,
2017) (Systematic Review 2). These systematic reviews identified the
following occupational ergonomic risk factors as relevant.
Regarding knee osteoarthritis, Verbeek et al. (2017) concluded in a
meta-analysis of 12 case control studies that measured exposure to
kneeling or squatting resulted in a summary OR of 1.7 (95% CI
1.35–2.13, I2 49%); exposure to lifting (11 studies) in an OR of 1.69
(95% CI 1.43–2.00, I2 51%); exposure to climbing (seven studies) in an
OR of 1.6 (95% CI 1.25–1.91, I2 68%) and a combination of kneeling
and lifting (one study) in an OR of 1.35 (95% CI 1.05–1.73) (Verbeek
et al., 2017).
A recent meta-analysis, based on 7 studies, revealed moderate
quality evidence for associations between shoulder disorders (M75.1-
M75.5) and arm elevation (odds ratio (OR) 1.9, 95% confidence in-
terval (CI) 1.47 to 2.47, I2 31%) and shoulder load, a combined bio-
mechanical exposure measure (OR=2.0, 95% CI 1.90 to 2.10, I2 0%)
and low to very low evidence for hand force exertion (OR=1.5, 95%
CI 1.25 to 1.87, I2 66%), and hand-arm vibration (OR=1.3, 95% CI
1.01 to 1.77, I2 99%) (van der Molen et al., 2017). van Rijn et al. (2010)
performed a systematic review on the relationship between work-re-
lated factors and specific disorders of the shoulder and found in the 17
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included studies that repetitive movements of the shoulder, repetitive
motion of the hand/wrist of> 2 h/day, hand–arm vibration, and arm
elevation showed an association with subacromial impingement syn-
drome (ORs between: 1.04, 95% CI 1.00–1.07 and 4.7, 95% CI
2.07–10.68), as did upper-arm flexion of ≥45° for ≥15% of time (OR
2.43, 95% CI 1.04–5.68) and duty cycle of forceful exertions of ≥9%
time or any duty cycle of forceful pinch (OR 2.66, 95% CI 1.26–5.59)
(van Rijn et al., 2010).
Descatha et al. (2016) included in a meta-analysis five prospective
studies published between 2001 and 2014 and found a positive asso-
ciation between combined biomechanical exposure involving the wrist
and/or elbow and incidence of epicondylitis lateralis (OR 2.6, 95% CI
1.9–3.5) (Descatha et al., 2016). In a systematic review by van Rijn
et al. (2009) the associations between force, posture, repetitiveness,
hand-arm vibration and a mixture of these exposures and elbow dis-
orders were studied (van Rijn et al., 2009). Handling tools of> 1 kg
(ORs of 2.1–3.0), handling loads of> 20 kg at least ten times/day (OR
2.6) and repetitive movements for> 2 h/day (ORs of 2.8–4.7) were
associated with lateral epicondylitis, while handling loads of> 5 kg (2
times/min at minimum of 2 h/day), handling loads of> 20 kg for at
least ten times/day, high hand grip forces for> 1 h/day, repetitive
movements for> 2 h/day (ORs of 2.2–3.6) and working with vibrating
tools for> 2 h/day (OR 2.2) were all associated with medial epi-
condylitis.
Jensen (2008) evaluated the association between physical work
demands and hip osteoarthritis in 22 included studies and concluded
that moderate to strong evidence exists for a relation with heavy lifting
(OR ranges between 1.97, 95% CI 1.14–3.4, and 8.5 (95% CI 1.6–45.3)
(Jensen, 2008). Furthermore, thirteen studies showed a significantly
increased risk between farming and hip osteoarthritis, with ORs ranging
from 1.9 (95% CI 1.01–3.87) to 12.0 (95% CI 6.7–21.4). Lievense et al.
(2001) used a best-evidence synthesis to summarize the results of two
retrospective and 14 case-control studies and found moderate evidence
for a positive association between previous physical workload and hip
osteoarthritis, with ORs ranging from 1.5 (95% CI 0.9–2.5) and 9.3
(95% CI 1.9–44.5) (Lievense et al., 2001). In a subgroup analysis, also
≥10 years farming was positively related to hip osteoarthritis.
Work in the informal economy may lead to different exposures and
exposure effects than does work in the formal economy. The informal
economy is defined as “all economic activities by workers and economic
units that are – in law or in practice – not covered or insufficiently
covered by formal arrangements”, but excluding “illicit activities, in
particular the provision of services or the production, sale, possession
or use of goods forbidden by law, including the illicit production and
trafficking of drugs, the illicit manufacturing of and trafficking in
firearms, trafficking in persons, and money laundering, as defined in
the relevant international treaties” (p. 4) (104th International Labour
Conference, 2015). Therefore, we consider the formality of the
economy studied in studies included in both systematic reviews.
1.2. Description of the risk factors
The aforementioned seven systematic reviews on the effect of oc-
cupational ergonomic risk factors on musculoskeletal diseases of the
shoulder (van Rijn et al., 2010; van der Molen et al., 2017); elbow
(Descatha et al., 2016); hip (Jensen, 2008; Lievense et al., 2001); and
knee (Verbeek et al., 2017), and additional documents (Harris and
Coggon, 2015; European Agency for Safety and Health at Work, 2010)
have identified the seven following types of occupational ergonomic
risk factors as of interest: (i) force exertion (e.g., carrying or moving
heavy loads, turn and screw); (ii) demanding posture (e.g. arm eleva-
tion, bending and/or twisting); (iii) repetitiveness (e.g., physically re-
petitive work); (iv) hand-arm vibration; (v) kneeling and/or squatting;
(vi) lifting (e.g. lifting heavy loads); and/or (vii) climbing. We will
review studies on occupational exposure to any (i.e., one or more) of
these seven different ergonomic risk factors. The definition of the risk
factor, the risk factor levels and the theoretical minimum risk exposure
level are presented in Table 1. The WHO burden of disease study has
previously defined occupational ergonomic risk factors into four cate-
gories by occupation, these being background exposure (defined by
manager and professionals as occupations); low exposure (clerical and
sales workers); moderate exposure (operators and service workers); and
high exposure (farmers) (Murray et al., 2004). The Institute of Health
Metrics and Evaluation's burden of disease study has defined occupa-
tional ergonomic factors for low back and neck pain specifically as “All
individuals have the ergonomic factors of clerical and related workers”
(p. 1362) (G. B. D. Risk Factors Collaborators, 2017).
1.3. Description of the outcomes
In Systematic Review 2, we will review two outcomes:
1. Osteoarthritis of the hip or knee.
2. Any selected other musculoskeletal diseases, defined as one or more
of: shoulder disorders: rotator cuff syndrome, bicipital tendinitis,
calcific tendinitis, shoulder impingement, bursitis shoulder; elbow
disorders: epicondylitis medialis, epicondylitis lateralis, bursitis
elbow; hip disorders: trochanter and other hip bursitis; and knee
disorders: chondromalacia patella, meniscus disorders and bursitis
knee.
For the outcome “Any other selected musculoskeletal diseases”, only
diseases have been included, for which exposure to one or more of the
included occupational ergonomic risk factors (Table 1) is considered as
a necessary factor for disease development. This selection was mainly
based on the information about a possible occupational origin of the
selected health outcomes in the seven systematic reviews described
above (van der Molen et al., 2017; van Rijn et al., 2010;Descatha et al.,
2016; van Rijn et al., 2009; Jensen, 2008; Lievense et al., 2001; Verbeek
et al., 2017), plus additional evidence (Harris and Coggon, 2015;
European Agency for Safety and Health at Work, 2010).
The WHO Global Health Estimates group outcomes into standard
burden of disease categories (World Health Organization, 2017), based
on standard codes from the International Statistical Classification of Dis-
eases and Related Health Problems 10th Revision (ICD-10) (World Health
Organization, 2015). The relevant WHO Global Health Estimates cate-
gories for Systematic Review 2 are “II.M.2. Osteoarthritis” and “II.M.5.
Other musculoskeletal diseases” (World Health Organization, 2017).
Table 1
Definitions of the risk factor, risk factor levels and the minimum risk exposure level.
Risk factor Exposure to occupational ergonomic risk factors (defined as exposure occupationally to one or more of: force exertion, demanding
posture, repetitive movement, hand-arm vibration, kneeling or squatting, lifting and/or climbing)
Risk factor level Two levels:
1. No exposure to occupational ergonomic risk factors.
2. Any exposure to occupational ergonomic risk factors.
If possible, “any” exposure may be further classified into “moderate” and “high” exposure, preferably based on exposure in terms of
level, frequency and/or duration.
Theoretical minimum risk exposure level No exposure to occupational ergonomic risk factors
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Table 2 presents the pairs of occupational ergonomic risk factors and
the musculoskeletal diseases included in this review. Table 3 presents
for each disease or health problem included in the WHO Global Health
Estimates categories its inclusion in Systematic Review 2. For both ca-
tegories, this review does not cover all the relevant WHO Global Health
Estimates categories.
1.4. How the risk factors may impact the outcome
Fig. 1 presents the logic model for our systematic reviews of the
causal relationship between exposure to occupational ergonomic risk
factors and osteoarthritis, and selected other musculoskeletal diseases
respectively. This logic model is an a priori, process model (Rehfuess
et al., 2018) that seeks to capture complexity of the risk factor-outcome
causal relationship (Anderson et al., 2011).
Musculoskeletal diseases are multifactorial in origin, which means
that there may be several aetiological risk factors for their onset.
Specific potentially relevant pathomechanisms include: posturally in-
duced muscular imbalance, neural pathomechanisms, the ‘Cinderella
hypothesis’ of motor unit recruitment, reperfusion, impaired heat-shock
response and stress-induced mitochondrial damage (Forde et al., 2002).
Nevertheless, there currently is no clear and circumscriptive under-
standing of the pathogenesis of work-related musculoskeletal diseases.
One postulation is that musculoskeletal diseases result from cumulative
micro damage induced by risk factors on cellular and/or tissue level
over time.
2. Objectives
1. Systematic Review 1: To systematically review quantitative studies
of any design on the prevalence of relevant levels of exposure to
occupational ergonomic risk factors in the years 2005 to 2018
among working-age workers, disaggregated by country, sex, age and
industrial sector or occupation.
2. Systematic Review 2: To systematically review and meta-analyze
randomized control trials, cohort studies, case-control studies and
other non-randomized intervention studies with estimates of the
relative effect of any occupational exposure to ergonomic risk fac-
tors on osteoarthritis, and selected other musculoskeletal diseases
respectively, in any year among working-age workers, compared
with the minimum risk exposure level of no exposure.
3. Methods
We will apply the Navigation Guide (Woodruff and Sutton, 2014)
methodology for systematic reviews in environmental and occupational
health as our guiding methodological framework, wherever feasible.
The guide applies established systematic review methods from clinical
medicine, including standard Cochrane Collaboration methods for
systematic reviews of interventions, to the field of environmental and
occupational health to ensure systematic and rigorous evidence synth-
esis on environmental and occupational risk factors that reduces bias
and maximizes transparency (Woodruff and Sutton, 2014). The need for
further methodological development and refinement of the relatively
novel Navigation Guide has been acknowledged (Woodruff and Sutton,
2014).
Systematic Review 1 may not map well to the Navigation Guide
framework (Fig. 1 on page 1009 in (Lam et al., 2016c)), which is tai-
lored to hazard identification and risk assessment. Nevertheless, steps
1–6 for the stream on human data can be applied to systematically
review exposure to risk factors. Systematic Review 2 maps more closely
to the Navigation Guide framework, and we will conduct steps 1–6 for
the stream on human data, but not conduct any steps for the stream on
non-human data, although we will briefly summarize narratively the
evidence from non-human data that we are aware of.
We have registered the protocol in PROSPERO under
CRD42018102631. This protocol adheres with the preferred reporting
items for systematic review and meta-analysis protocols statement
(PRISMA-P) (Moher et al., 2015; Shamseer et al., 2015), with the ab-
stract adhering with the reporting items for systematic reviews in
journal and conference abstracts (PRISMA-A) (Beller et al., 2013). Any
modification of the methods stated in the present protocol will be re-
gistered in PROSPERO and reported in the systematic review itself
under the section ‘Differences between protocol and review’. Systematic
Review 1 will be reported according to the GATHER guidelines (Stevens
et al., 2016), and Systematic Review 2 will be reported according to the
preferred reporting items for systematic review and meta-analysis
statement (PRISMA) (Liberati et al., 2009). Our reporting of all para-
meters for estimating the burden of osteoarthritis, and other muscu-
loskeletal diseases respectively, from exposure to occupational ergo-
nomic risk factors in the systematic reviews will adhere with the
requirements of the GATHER guidelines (Stevens et al., 2016), because
the WHO/ILO burden of disease estimates that may be produced con-
secutive to the systematic review must also adhere to these reporting
guidelines.
3.1. Systematic Review 1
3.1.1. Eligibility criteria
The population, exposure, comparator and outcome (PECO) criteria
(Liberati et al., 2009) are described below.
3.1.1.1. Types of populations. We will include studies of the working-
age population (≥15 year) in the formal and informal economy. Studies
of children (< 15 years) and unpaid domestic workers will be excluded.
Participants residing in any WHO and/or ILO Member State and
workers in any industrial setting and occupation will be included.
Appendix A provides a brief overview of the PECO criteria.
3.1.1.2. Types of exposures. We will include studies that define
exposure to occupational ergonomic risk factors in accordance with
our standard definition (Table 1). For osteoarthritis of hip or knee, and
any selected other musculoskeletal disease respectively, cumulative
exposure (e.g. total number of years or total amount of work performed
according to one's job history) may be the most biologically relevant
exposure metric in theory, but – as done in other burden of disease
studies – we will here also prioritize a non-cumulative exposure metric
in practice (i.e. exposure in present work calculated solemnly on a daily
Table 2
Pairs of occupational ergonomic risk factors and musculoskeletal diseases included in this review.
Pair Risk factor Disease or health problems
1 Exposure to occupational force exertion M16, M17, M22.4, M23.0, M23.2, M23.3, M23.4, M70.0-M70.7, M75.1-M75.5, M70.0-M70.1
2 Exposure to occupational demanding posture M22.4, M23.0, M23.2, M23.3, M23.4, M70.0-M70.7, M75.1-M75.5, M70.0-M70.1
3 Exposure to occupational repetitive body movement M22.4, M23.0, M23.2, M23.3, M23.4, M70.0-M70.7, M75.1-M75.5, M70.0-M70.1
4 Exposure to occupational hand-arm vibration M70.0-M70.3, M75.1-M75.5
5 Exposure to occupational kneeling and/or squatting M17, M22.4, M70.4-M70.5
6 Exposure to occupational lifting M16, M17,
7 Exposure to occupational climbing M17
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basis and not taking into account the total exposure history). We
believe that insufficient cumulative exposure data currently exist to
enable burden of disease estimation.
We will include studies on the prevalence of exposure to the re-
spective occupational risk factor, if it is disaggregated by country (de-
fined as a WHO and/or ILO Member State), sex (two categories: female,
male), age (ideally in 5-year age bands, such as 20–24 years) and in-
dustrial sector (e.g., International Standard Industrial Classification of All
Economic Activities, Revision 4 [ISIC Rev. 4]) (United Nations, 2008) or
occupation (as defined, for example, by the International Standard
Classification of Occupations 1988 [ISCO-88] (International Labour
Organization, 1987) or 2008 [ISCO-08] (International Labour
Organization, 2012)). Criteria may be revised in order to identify op-
timal data disaggregation to enable subsequent estimation of the
burden of disease.
We shall include studies with exposure data for the years 2005 to 31
July 2018. For optimal modelling of exposure, WHO and ILO require
exposure data up to 2018, because recent data points help better esti-
mate time trends, especially where data points may be sparse. The
additional rationale for this data collection window is that the WHO
and ILO aim to estimate burden of disease in the year 2015, and we
believe that the lag time from exposure to outcome will not exceed
10 years (Haibing et al., 2006); so in their models, the organizations can
use the exposure data from as early as 2005 to determine the burden of
osteoarthritis of hip or knee, and the selected other musculoskeletal
diseases respectively, 10 years later in 2015. To make a conclusive
judgment on the best lag time to apply in the model, we will summarize
the body of evidence on the lag time between exposure to occupational
ergonomic risk factors and osteoarthritis of hip or knee, and any se-
lected other musculoskeletal disease respectively in the review.
Both objective and subjective measures will be included. If both
subjective and objective measures are presented, then we will prioritize
objective ones. Studies with measures from any data source, including
registries, will be eligible. The exposure parameter should match the
one used in Systematic Review 2 or can be converted to match it.
3.1.1.3. Types of comparators. There will be no comparator, because we
will review risk factor prevalence only.
3.1.1.4. Types of outcomes. The outcome is exposure to the
occupational risk factor (i.e., ergonomic risk factors).
3.1.1.5. Types of studies. This systematic review will include
quantitative studies of any design, including cross-sectional studies.
These studies must be representative of the relevant industrial sector,
relevant occupational group or the national population. We will
exclude qualitative, modelling and case studies, as well as non-
original studies without quantitative data (e.g. letters, commentaries
and perspectives).
Study records written in any language will be included. If a study
record is written in a language other than those spoken by the authors
of this review or those of other reviews (Descatha et al., 2018; Godderis
et al., 2018; Li et al., 2018; Mandrioli et al., 2018; Paulo et al., 2018;
Rugulies et al., Accepted; Teixeira et al., 2018; Tenkate et al., 2018) in
the series (i.e. Arabic, Bulgarian, Chinese, Danish, Dutch, English,
French, Finnish, German, Hungarian, Italian, Japanese, Norwegian,
Portuguese, Russian, Spanish, Swedish and Thai), it will be translated
into English. Published and unpublished studies will be included.
Studies conducted using unethical practices will be excluded from
the review.
3.1.1.6. Types of effect measures. We will include studies with a
measure of the prevalence of exposure to occupational ergonomic risk
factors.
3.1.2. Information sources and search
3.1.2.1. Electronic academic databases. We (JGD, HFVM, SM and SN)
will at a minimum search the five following electronic academic
databases:
1. Ovid Medline with Daily Update (1 January 2005 to 31 July 2018).
2. PubMed (1 January 2005 to 31 July 2018).
3. EMBASE (1 January 2005 to 31 July 2018).
4. Web of Science with inclusion of three databases: Science Citation
Table 3
ICD-10 codes and disease and health problems covered by the WHO Global
Health Estimates categories “II.M.2. Osteoarthritis” and “II.M.5. Other muscu-
loskeletal diseases” and their inclusion in Systematic Review 2.
ICD-10 code Disease or health problems (or
groups of diseases)
Inclusion in
Systematic Review
2
II.M.2. Osteoarthritis
M15 Polyarthrosis No
M16 Coxarthrosis [arthrosis of hip] Yes
M17 Gonarthrosis [arthrosis of knee] Yes
M18 Arthrosis of first carpometacarpal
joint
No
M19 Other arthrosis No
II.M.5. Other musculoskeletal diseases
M00 Pyogenic arthritis No
M02 Reactive arthropathies No
M08 Juvenile arthritis No
M11 Other crystal arthropathies No
M12 Other specific arthropathies No
M13 Other arthritis No
M20 Acquired deformities of fingers and
toes
No
M21 Other acquired deformities of limbs No
M22 (except M22.4) Disorders of patella No
M22.4 Chondromalacia patellae Yes
M23 (except M23.0,
M23.2, M23.3)
Internal derangement of knee No
M23.0 Cystic meniscus Yes
M23.2 Derangement of meniscus due to old
tear or injury
Yes
M23.3 Other meniscus derangements Yes
M23.4 Loose body in knee Yes
M24 Other specific joint derangements No
M25 Other joint disorders, not classified No
M30–36 Systemic connective tissue disorders No
M40-M43 Deforming dorsopathies No
M60-M63 Disorders of muscles No
M70.0 - M70.1 Bursitis & synovitis hand, wrist Yes
M70.2 - M70.3 Olecranon & other elbow bursitis Yes
M70.4 - M70.5 Prepatellaris & other knee bursitis Yes
M70.6 - M70.7 Trochanter & other hip bursitis Yes
M71-M73 Other bursopathies, fibroblastic
disorders, soft tissue disorders in
diseases classified elsewhere
No
M75 (except M75.1-
M75.5)
Shoulder lesions No
M75.1 Rotator cuff syndrome Yes
M75.2 Bicipital tendinitis Yes
M 75.3 Calcific tendinitis of shoulder Yes
M75.4 Impingement syndrome of shoulder Yes
M75.5 Bursitis of shoulder Yes
M76 Enthesopathies lower limb No
M77 (except M77.0-
M77.1)
Other enthesopathies No
M77.0 Epicondylitis medialis Yes
M77.1 Epicondylitis lateralis Yes
M80–85 Disorders of bone density and
structure
No
M86–90 Other osteopathies No
M91–M94 Chondropathies No
M95 Other acquired deformities No
M96 Postprocedural musculoskeletal
disorders
No
M99 Biomechanical lesions, not elsewhere No
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Index Expanded (1 January 2005 to 31 July 2018); Social Sciences
Citation Index (1 January 2005 to 31 July 2018); and Arts and
Humanities Citation Index (1 January 2005 to 31 July 2018).
5. OSH UPDATE with inclusion of three databases: CISDOC (1 January
2005 to 31 July 2018); HSELINE (1 January 2005 to 31 July 2018);
and NIOSHTIC-2 (1 January 2005 to 31 July 2018).
The Ovid Medline search strategy for Systematic Review 1 is pre-
sented in Appendix B. We will perform searches in electronic databases
operated in the English language using a search strategy in the English
language. Consequently, study records that do not report essential in-
formation (i.e. title and abstract) in English will not be captured. We
will adapt the search syntax to suit the other electronic academic and
grey literature databases. When we are nearing completion of the re-
view, we will search the PubMed database for the most recent pub-
lications (e.g., e-publications ahead of print) over the last six months.
Any deviation from the planned search strategy in the actual search
strategy will be documented.
3.1.2.2. Electronic grey literature databases. JGD, PK, FM and HFVM will
at a minimum search the two following electronic grey literature
databases:
1. OpenGrey (http://www.opengrey.eu/).
2. Grey Literature Report (http://greylit.org/).
3.1.2.3. Internet search machines. We (JGD, FM, HFVM and SN) will
also search the Google (www.google.com/) and Google Scholar (www.
google.com/scholar/) Internet search engines and screen the first 100
hits for potentially relevant records, as has been done previously in
Cochrane Reviews (Pega et al., 2015; Pega et al., 2017).
3.1.2.4. Organizational websites. At a minimum, the websites of the
eight following international organizations and national government
departments will be searched by PK, PPMFK and FM:
1. International Labour Organization (www.ilo.org/).
2. World Health Organization (www.who.int).
3. European Agency for Safety and Health at Work (https://osha.
europa.eu/en).
4. Eurostat (www.ec.europa.eu/eurostat/web/main/home).
5. China National Knowledge Infrastructure (http://www.cnki.net/).
6. Finnish Institute of Occupational Health (https://www.ttl.fi/en/).
7. United States National Institute of Occupational Safety and Health
(NIOSH), using the NIOSH data and statistics gateway (https://
www.cdc.gov/niosh/data/).
8. International Ergonomics Association (http://www.iea.cc/).
3.1.2.5. Hand-searching and expert consultation. We (CTJH, PPMFK, FM
and SN) will hand-search for potentially eligible studies in:
• Reference lists of previous systematic reviews.• Reference lists of all study records of all included studies.• Study records published over the past 24months in the three peer-
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334 
Context 
Governance, policy and cultural and societal norms and values 
The changing world of work 
Risk factor 
Any ergonomic risk factors 
Mediators
Tasks performed, load on 
the musculoskeletal system, 
psychosocial demands, 
social support, decision 
latitude, job control, job 
security, long working hours 
and work-related stress 
Outcomes 
Osteoarthritis of hip or knee 
Any selected other 
musculoskeletal disease 
Confounders 
Age, sex, 
socioeconomic 
position, body mass 
index, smoking 
status, comorbidity 
and sporting and/or 
leisure activities 
Effect modifiers 
Country, age, sex, 
industrial sector, 
occupation and 
formality of economy 
Fig. 1. Logic model of the possible causal relationship between exposure to occupational ergonomic risk factors and osteoarthritis of hip or knee and selected other
musculoskeletal diseases.
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reviewed academic journals from which we obtain the largest
number of included studies.• Study records that have cited an included study record (identified in
Web of Science citation database).• Collections of the review authors.
Additional experts will be contacted with a list of included studies
and study records, with the request to identify potentially eligible ad-
ditional ones.
3.1.3. Study selection
Study selection will be carried out with Covidence (Babineau, 2014;
Covidence Systematic Review Software) or the Rayyan Systematic Re-
views Web App (Ouzzani et al., 2016). All study records identified in
the search will be downloaded and duplicates will be identified and
deleted. Afterwards, two review authors (HFVM and SN) will in-
dependently screen titles and abstracts (step 1) and then full texts (step
2) of potentially relevant records. A third review author (PPMFK) will
resolve any disagreements between the two review authors. If a study
record identified in the literature search was authored by a review
author assigned to study selection or if a assigned review author was
involved the study that the study record reports, then the record will be
re-assigned to another review author for study selection. In the sys-
tematic review, we will document the study selection in a flow chart, as
per GATHER guidelines (Stevens et al., 2016).
3.1.4. Data extraction and data items
A data extraction form will be developed and piloted until there is
convergence and agreement among data extractors. At a minimum,
three review authors (FM, HFVM and SN) will independently extract
the data on exposure to ergonomic risk factors, disaggregated by
country, sex, age and industrial sector or occupation. A fourth and fifth
review author (CTJH and CHN) will resolve conflicting extractions, if
any. At a minimum, we will extract data on study characteristics (in-
cluding study authors, study year, study country, participants and ex-
posure), study design (including study type and measurement of oc-
cupational exposure with the risk factor), risk of bias (including missing
data, as indicated by response rate and other measures) and study
context. The estimates of the proportion of the population that is ex-
posed to the occupational risk factor from included studies will be en-
tered into and managed with the Review Manager, Version 5.3
(RevMan 5.3) (Review Manager (RevMan). Version 5.3, 2014) or Dis-
tillerSR (EvidencePartner, 2017) softwares.
We will also extract data on potential conflict of interest in included
studies, including the financial disclosures and funding sources of each
author and their affiliated organization. We will use a modification of a
previous method to identify and assess undisclosed financial interests
(Forsyth et al., 2014). Where no financial disclosure/conflict of interest
is provided, we will search declarations of interest both in other records
from this study published in the 36months prior to the included study
record and in other publicly available repositories (Drazen et al., 2010a;
Drazen et al., 2010b).
If we require any missing data, we will request these from the
principal study author by email or phone, using the contact details
provided in the principal study record. If we do not receive a response,
we will follow up twice via email, at two and four weeks.
3.1.5. Risk of bias assessment
Generally agreed methods (i.e. framework plus tool) for assessing
risk of bias do not exist for systematic reviews of input data for health
estimates (The GATHER Working Group, 2016), for burden of disease
studies, of prevalence studies in general (Munn et al., 2014), and those
of prevalence studies of occupational and/or environmental risk factors
specifically (Krauth et al., 2013; Mandrioli and Silbergeld, 2016;
Vandenberg et al., 2016). None of the five standard risk of bias as-
sessment methods in systematic reviews in environmental and
occupational health (Rooney et al., 2016) are applicable to assessing
prevalence studies. The Navigation Guide does not support checklist
approaches, such as (Hoy et al., 2012; Munn et al., 2014), for assessing
risk of bias in prevalence studies.
We will use a modified version of the Navigation Guide risk of bias
tool (Lam et al., 2016c) that we developed specifically for Systematic
Review 1 (Appendix D). We will assess risk of bias on the levels of the
individual study and the entire body of evidence. As per our pre-
liminary tool, we will assess risk of bias along five domains: (i) selection
bias; (ii) performance bias; (iii) misclassification bias; (iv) conflict of
interest; and (v) other biases. Risk of bias will be: “low”; “probably
low”; “probably high”; “high” or “not applicable”. To judge the risk of
bias in each domain, we will apply our a priori instructions (Appendix
D).
All risk of bias assessors (PPMFK, SM and SN) will trial the tool until
they have synchronized their understanding and application of each
risk of bias domain, considerations and criteria for ratings. At least two
study authors (out of: PPFMK, SM and SN) will then independently
judge the risk of bias for each study by outcome and discuss any dif-
ferences in order to come to consensus. A third author (MHWF) will
resolve any conflicting judgments. We will present the findings of our
risk of bias assessment for each eligible study in a standard ‘Risk of bias’
table (Higgins et al., 2011). Our risk of bias assessment for the entire
body of evidence will be presented in a standard ‘Risk of bias summary’
figure (Higgins et al., 2011).
3.1.6. Synthesis of results
We will neither produce any summary measures, nor synthesise the
evidence quantitatively. The included evidence will be presented in
what could be described as an ‘evidence map’. All included data points
from included studies will be presented, together with meta-data on the
study design, number of participants, characteristics of population,
setting, and exposure measurement of the data point.
3.1.7. Quality of evidence assessment
There is no agreed method for assessing quality of evidence in
systematic reviews of the prevalence of occupational and/or environ-
mental risk factors We will adopt/adapt from the latest Navigation Guide
instructions for grading (Lam et al., 2016c), including criteria (Ap-
pendix D). We will downgrade for the following five reasons from the
Grading of Recommendations Assessment, Development and Evaluation
(GRADE) approach: (i) risk of bias; (ii) inconsistency; (iii) indirectness;
(iv) imprecision; and (v) publication bias (Schünemann et al., 2011).
We will grade the evidence, using the three Navigation Guide quality of
evidence ratings: “high”, “moderate” and “low” (Lam et al., 2016c).
Within each of the relevant reasons for downgrading, we will rate any
concern per reason as “none”, “serious” or “very serious”. We will start
at “high” for non-randomized studies and will downgrade for no con-
cern by nil, for a serious concern by one grade (−1), and for a very
serious concern by two grades (−2). For example, if we have a serious
concern for risk of bias in the body of evidence (−1) and a very serious
concern for inconsistency (−2), We will downgrade the quality of
evidence by a total of three grades (−3) from “high” to “low”. We will
not up-grade or down-grade the quality of evidence for the three other
reasons normally considered in GRADE assessments (i.e. large effect,
dose-response and plausible residual confounding and bias), because
we consider them irrelevant for prevalence estimates.
All quality of evidence assessors (HFVM, SM and SN) will trial the
application of our instructions and criteria for quality of evidence as-
sessment until their understanding and application is synchronized. At
least two study authors (out of: HFVM, SM and SN) will independently
judge the quality of evidence for the entire body of evidence by out-
come. A third review author (CTJH or CHN) will resolve any conflicting
judgments. In the systematic review, for each outcome, for each out-
come, we will present our assessments of the risk for each GRADE do-
main, as well as an overall GRADE rating.
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3.1.8. Strength of evidence assessment
To our knowledge, no agreed method exists for rating strength of
evidence in systematic reviews of prevalence studies, including those of
occupational and/or environmental risk factors. We (HFVM, SN and
SM) will rate the strength of the evidence for use as input data for es-
timating national-level exposure with the risk factor. Our rating will be
based on a combination of the following four criteria: (i) quality of the
entire body of evidence; (ii) population coverage of evidence (WHO
regions and countries); (iii) confidence in the entire body of evidence;
and (iv) other compelling attributes of the evidence that may influence
certainty. We will rate the strength of the evidence as either “poten-
tially sufficient” or “potentially inadequate” for use as input data
(Appendix E).
3.2. Systematic Review 2
3.2.1. Eligibility criteria
The PECO (Liberati et al., 2009) criteria are described below.
3.2.1.1. Types of populations. We will include studies of working-age
(≥15 year) workers in the formal and informal economy. Studies of
children (aged< 15 years) and unpaid domestic workers will be
excluded. Participants residing in any WHO and/or ILO Member State
and workers in any industrial setting and occupation will be included.
Appendix F provides a briefer overview of the PECO criteria.
3.2.1.2. Type of exposure. We will include studies that define exposure
to occupational ergonomic risk factors in accordance with our standard
definition (Table 1). We will include studies where exposure to
occupational ergonomic risk factors was measured, whether
objectively (e.g. by means of technology) or subjectively, including
studies that used measurements by experts (e.g. scientists with subject
matter expertise) and self-reports by the worker or workplace
administrator or manager. If a study presents both objective and
subjective measurements, then we will prioritize objective
measurements. However, if we consider the subjective measure to be
clearly preferable, then we will prioritize it and provide a justification
for this prioritization in the systematic review. We will include studies
with measures from any data source, including registry data. Studies
from any year will be included.
3.2.1.3. Type of comparators. The included comparator will be
participants exposed to the theoretical minimum risk exposure level
(Table 1). We will exclude all other comparators.
3.2.1.4. Types of outcomes. We will include studies that defined
osteoarthritis of hip or knee, and any selected other musculoskeletal
diseases respectively, in accordance with our standard definition of
these outcomes (Table 3). We will only include binary measures
(present versus not present) of clinically assessed eligible
osteoarthritis of hip or knee, and any selected other musculoskeletal
diseases, respectively. Prevalence and incidence of eligible diseases will
be included, but mortality will be excluded.
The following measurements of osteoarthritis, and any other mus-
culoskeletal disease respectively, will be regarded as eligible:
i) Diagnosis by a physician.
ii) Hospital admission or discharge record.
iii) Other relevant administrative data (e.g. record of sickness absence
or disability).
iv) Registry data of treatment for osteoarthritis of hip or knee and any
selected other musculoskeletal disease, respectively.
All other measures will be excluded from this systematic review.
We will include objective measures of these eligible musculoskeletal
diseases (e.g., measured by an occupational health and safety
practitioner, such as an occupational physician or nurse, using a vali-
dated tool), as well as subjective measures (e.g., measured by a worker).
If subjective and objective measures are presented, then we will
prioritize objective measures.
3.2.1.5. Types of studies. We will include studies that investigate the
effect of exposure to any occupational risk factor on osteoarthritis of hip
or knee, and any selected other musculoskeletal diseases respectively,
for any years. Eligible study designs will be randomized controlled
trials (including parallel-group, cluster, cross-over and factorial trials),
cohort studies (both prospective and retrospective), case-control
studies, and other non-randomized intervention studies (including
quasi-randomized controlled trials, controlled before-after studies and
interrupted time series studies). We included a broader set of
observational study designs than is commonly included, because a
recent augmented Cochrane Review of complex interventions identified
valuable additional studies using such a broader set of study designs
(Arditi et al., 2016). As we have an interest in quantifying risk and not
in qualitative assessment of hazard (Barroga and Kojima, 2013), we will
exclude all other study designs (e.g. uncontrolled before-and-after,
cross-sectional, qualitative, modelling, case and non-original studies).
Records published in any year and any language will be included.
Again, the search will be conducted using English language terms, so
that records published in any language that present essential informa-
tion (i.e. title and abstract) in English will be included. If a record is
written in a language other than those spoken by the authors of this
review or those of other reviews in the series, then the record will be
translated into English. Published and unpublished studies will be in-
cluded.
Studies conducted using unethical practices will be excluded from
the review (e.g., studies that deliberately exposed humans to a known
risk factor to human health).
3.2.1.6. Types of effect measures. We will include measures of the
relative effect of any exposure to occupational ergonomic risk factors
on the prevalence or incidence of osteoarthritis of hip or knee and any
selected other musculoskeletal disease respectively, compared with the
theoretical minimum risk exposure level of no exposure. Effect
estimates of mortality measures only will be excluded. We will
include relative effect measures such as risk ratios and odds ratios for
prevalence measures and hazard ratios for incidence measures (e.g.,
developed osteoarthritis and any musculoskeletal disease, respectively).
Measures of absolute effects (e.g. mean differences in risks or odds) will
be converted into relative effect measures, but if conversion is
impossible, they will be excluded. To ensure comparability of effect
estimates and facilitate meta-analysis, if a study presents an odds ratio,
then we will convert it into a risk ratio, using the guidance provided in
the Cochrane Collaboration's handbook for systematic reviews of
interventions (Higgins and Green, 2011).
As shown in our logic framework (Fig. 1), we a priori consider the
following variables to be potential effect modifiers of the effect of long
working hours on stroke: country, age, sex, industrial sector, occupa-
tional group and formality of employment. We consider age, sex, so-
cioeconomic position, body mass index, smoking status, comorbidity
and sporting and/or leisure activities to be potential confounders. Po-
tential mediators are tasks performed, load on the musculoskeletal
system, psychosocial demands, social support, decision latitude, job
control, job security, long working hours and work-related stress.
If a study presents estimates for the effect from two or more alter-
native models that have been adjusted for different variables, then we
will systematically prioritize the estimate from the model that we
consider best adjusted, applying the lists of confounders and mediators
identified in our logic model (Fig. 1). We will prioritize estimates from
models adjusted for more potential confounders over those from models
adjusted for fewer. For example, if a study presents estimates from a
crude, unadjusted model (Model A), a model adjusted for one potential
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confounder (Model B) and a model adjusted for two potential con-
founders (Model C), then we will prioritize the estimate from Model C.
We will prioritize estimates from models unadjusted for mediators over
those from models that adjusted for mediators, because adjustment for
mediators can introduce bias. For example, if Model A has been ad-
justed for two confounders, and Model B has been adjusted for the same
two confounders and a potential mediator, then we will choose the
estimate from Model A over that from Model B. We prioritize estimates
from models that can adjust for time-varying confounders that are at
the same time also mediators, such as marginal structural models (Pega
et al., 2016), over estimates from models that can only adjust for time-
varying confounders, such as fixed-effects models (Gunasekara et al.,
2014), over estimates from models that cannot adjust for time-varying
confounding. If a study presents effect estimates from two or more
potentially eligible models, then we will explain specifically why we
prioritized the selected model.
3.2.2. Information sources and search
3.2.2.1. Electronic academic databases. At a minimum, we (JGD, HFVM,
SM and SN) will search the six following electronic academic databases:
1. International Clinical Trials Register Platform (to 31 July 2018).
2. Ovid Medline with Daily Update (1 January 1946 to 31 July 2018).
3. PubMed (1 January 1946 to 31 July 2018).
4. EMBASE (1 January 1947 to 31 July 2018).
5. Web of Science with inclusion of three databases: Science Citation
Index Expanded (1 January 1900 to 31 July 2018); Social Sciences
Citation Index (1 January 1956 to 31 July 2018); Arts and
Humanities Citation Index (1 January 1975 to 31 July 2018).
6. OSH UPDATE with inclusion of three databases: CISDOC (1 January
1974 to 31 July 2018); HSELINE (1 January 1977 to 31 July 2018);
NIOSHTIC-2 (1 January 1977 to 31 July 2018).
The Ovid Medline search strategy for Systematic Review 2 is pre-
sented in Appendix G. To identify studies on musculoskeletal diseases,
we have adopted or adapted several search terms or strings used in
recent Cochrane Reviews on professional interventions for general
practitioners on the management of musculoskeletal conditions
(Tzortziou Brown et al., 2016) and ergonomic design and training for
preventing work-related musculoskeletal diseases of the upper limb and
neck in adults (Hoe et al., 2012). We will perform searches in electronic
databases operated in the English language using a search strategy in
the English language. We will adapt the search syntax to suit the other
electronic academic and grey literature databases. When we are nearing
completion of the review, we will search the PubMed database for the
most recent publications (e.g., e-publications ahead of print) over the
last six months. Any deviation from the proposed search strategy in the
actual search strategy will be documented.
3.2.2.2. Electronic grey literature databases. At a minimum, we (JGD,
HFVM, SM and SN) will search the two following electronic grey
literature databases:
1. OpenGrey (http://www.opengrey.eu/).
2. Grey Literature Report (http://greylit.org/).
3.2.2.3. Internet search engines. We (JGD, HFVM, SM and SN) will also
search the Google (www.google.com/) and Google Scholar (www.
google.com/scholar/) Internet search engines and screen the first 100
hits for potentially relevant records.
3.2.2.4. Organizational websites. The websites of the eight following
international organizations and national government departments will
be searched by PK, PPMFK and CC:
1. International Labour Organization (www.ilo.org/).
2. World Health Organization (www.who.int).
3. EU-OSHA (https://osha.europa.eu/en).
4. EUROSTAT (www.ec.europa.eu/eurostat/web/main/home).
5. China National Knowledge Infrastructure (CNKI) (http://www.cnki.
net/).
6. Finnish Institute of Occupational Health (https://www.ttl.fi/en/).
7. National Institute of Occupational Safety and Health (NIOSH) of the
United States of America, using the NIOSH data and statistics
gateway (https://www.cdc.gov/niosh/data/).
8. International Ergonomics Association (http://www.iea.cc/).
3.2.2.5. Hand-searching and expert consultation. We (CTJH, PPMFK, SM
and SN) will hand-search for potentially eligible studies in:
• Reference lists of previous systematic reviews.• Reference lists of all included study records.• Study records published over the past 24months in the three peer-
reviewed academic journals with the largest number of included
studies.• Study records that have cited the included studies (identified in Web
of Science citation database).• Collections of the review authors.
Additional experts will be contacted with a list of included studies,
with the request to identify potentially eligible additional studies.
3.2.3. Study selection
Study selection will be carried out with Covidence (Babineau, 2014;
Covidence Systematic Review Software) or the Rayyan Systematic Re-
views Web App (Ouzzani et al., 2016). All study records identified in
the search will be downloaded and duplicates will be identified and
deleted. Afterwards, at least two review authors per health outcome
area (out of: PK, PPFMK, FM, HFVM, SM and SN) will independently
screen titles and abstracts (step 1) and then full texts (step 2) of po-
tentially relevant records. A third review author (out of: CC, CTJH and
CHN) will resolve any disagreements between the two review authors
for the different health outcomes. If a study record identified in the
literature search was authored by a review author assigned to study
selection or if a assigned review author was involved the study that the
study record reports, then the record will be re-assigned to another
review author for study selection. The study selection will be docu-
mented in a flow chart in the systematic review, as per PRISMA
guidelines (Liberati et al., 2009).
3.2.4. Data extraction and data items
A data extraction form will be developed and trialed until data ex-
tractors reach convergence and agreement. At a minimum, two review
authors (out of: PK, PPFMK, FM, HFVM, SM and SN) will extract data
on study characteristics (including study authors, study year, study
country, participants, exposure and outcome), study design (including
summary of study design, comparator, epidemiological models used
and effect estimate measure), risk of bias (including selection bias, re-
porting bias, confounding and reverse causation) and study context
(e.g., data on contemporaneous exposure to other occupational risk
factors potentially relevant for health loss from osteoarthritis and any
other musculoskeletal disease, respectively). A third review author (out
of: CC, MHWF and CHN) will resolve conflicts in data extraction, if any.
Data will be entered into and managed with the RevMan 5.3 (Review
Manager (RevMan). Version 5.3, 2014) or DistillerSR (EvidencePartner,
2017) computer softwares.
We will also extract data on potential conflict of interest in included
studies. For each author and affiliated organization of each included
study record, we will extract their financial disclosures and funding
sources. We will use a modification of a previous method to identify and
assess undisclosed financial interest of authors (Forsyth et al., 2014).
Where no financial disclosure or conflict of interest statements are
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available, we will search the name of all authors in other study records
gathered for this study and published in the prior 36months and in
other publicly available declarations of interests (Drazen et al., 2010a;
Drazen et al., 2010b).
If relevant data are missing, we will contact the principal study
author, using the email address provided in the principal study record,
with a request to provide the missing data. If we do not receive a po-
sitive response from the study author, we will send follow-up emails
twice, namely at two and four weeks.
3.2.5. Risk of bias assessment
Standard risk of bias tools do not exist for systematic reviews for
hazard identification in occupational and environmental health, nor for
risk assessment. The five methods specifically developed for occupa-
tional and environmental health are for either or both hazard identifi-
cation and risk assessment, and they differ substantially in the types of
studies (randomized, observational and/or simulation studies) and data
(e.g. human, animal and/or in vitro) they seek to assess (Rooney et al.,
2016). However, all five methods, including the Navigation Guide (Lam
et al., 2016c), assess risk of bias in human studies similarly (Rooney
et al., 2016).
The Navigation Guide was specifically developed to translate the
rigor and transparency of systematic review methods applied in the
clinical sciences to the evidence stream and decision context of en-
vironmental health (Woodruff and Sutton, 2014), which includes
workplace environment exposures and associated health outcomes. The
guide is our overall organizing framework, and we will also apply its
risk of bias assessment method in Systematic Review 2. The Navigation
Guide risk of bias assessment method builds on the standard risk of bias
assessment methods of the Cochrane Collaboration (Higgins et al.,
2011) and the US Agency for Healthcare Research and Quality
(Viswanathan et al., 2008). Some further refinements of the Navigation
Guide method may be warranted (Goodman et al., 2017), but it has
been successfully applied in several completed and ongoing systematic
reviews (Johnson et al., 2014; Koustas et al., 2014; Lam et al., 2014;
Vesterinen et al., 2014; Johnson et al., 2016; Lam et al., 2016b; Lam
et al., 2017; Lam et al., 2016a). In our application of the Navigation
Guide method, we will draw heavily on one of its latest versions, as
presented in the protocol for an ongoing systematic review (Lam et al.,
2016c). Should a more suitable method become available, we may
switch to it.
We will assess risk of bias on the individual study level and on the
body of evidence overall. The nine risk of bias domains included in the
Navigation Guide method for human studies are: (i) source population
representation; (ii) blinding; (iii) exposure assessment; (iv) outcome
assessment; (v) confounding; (vi) incomplete outcome data; (vii) se-
lective outcome reporting; (viii) conflict of interest; and (ix) other
sources of bias. While two of the earlier case studies of the Navigation
Guide did not utilize outcome assessment as a risk of bias domain for
studies of human data (Johnson et al., 2014; Koustas et al., 2014; Lam
et al., 2014; Vesterinen et al., 2014), all of the subsequent reviews have
included this domain (Johnson et al., 2016; Lam et al., 2016b; Lam
et al., 2017; Lam et al., 2016a; Lam et al., 2016c). Risk of bias or
confounding ratings will be: “low”; “probably low”; “probably high”;
“high” or “not applicable” (Lam et al., 2016c). To judge the risk of bias
in each domain, we will apply a priori instructions (Appendix H), which
we have adopted or adapted from an ongoing Navigation Guide sys-
tematic review (Lam et al., 2016c)). For example, a study will be as-
sessed as carrying “low” risk of bias from source population re-
presentation, if we judge the source population to be described in
sufficient detail (including eligibility criteria, recruitment, enrollment,
participation and loss to follow up) and the distribution and char-
acteristics of the study sample to indicate minimal or no risk of selec-
tion effects. The risk of bias at study level will be determined by the
worst rating in any bias domain for any outcome. For example, if a
study is rated as “probably high” risk of bias in one domain for one
outcome and “low” risk of bias in all other domains for the outcome and
in all domains for all other outcomes, the study will be rated as having a
“probably high” risk of bias overall.
All risk of bias assessors (CC, CTJH, FM, HFVM, SM, PK, PPFMK,
CHN and SN) will jointly trial the application of the risk of bias criteria
until they have synchronized their understanding and application of the
criteria. At least two study authors (out of: PK, PPFMK, FM, HFVM, SM
and SN) will independently judge the risk of bias for each study by
outcome. Where individual assessments differ, a third author (CC, CTJH
or CHN) will resolve the conflict. In the systematic review, for each
included study, we will report our study-level risk of bias assessment by
domain in a standard ‘Risk of bias’ table (Higgins et al., 2011). For the
entire body of evidence, we will present the study-level risk of bias
assessments in a ‘Risk of bias summary’ figure (Higgins et al., 2011).
3.2.6. Summary measures and synthesis of results
We will conduct meta-analyses separately for estimates of the effect
on prevalence and incidence. If we find two or more studies with an
eligible effect estimate (Table 2), two review authors (out of: PK,
PPFMK, FM, HFVM, SM and SN) will independently investigate the
clinical heterogeneity of the studies in terms of participants (including
country, sex, age and industrial sector or occupation), level of risk
factor exposure, comparator and outcomes. If we find that effect esti-
mates differ considerably by country, sex and/or age, or a combination
of these, then we will synthesise evidence for the relevant populations
defined by country, sex and/or age, or combination thereof. Differences
by country could include or be expanded to include differences by
country group (e.g. WHO region or World Bank income group). If we
find that effect estimates are clinically homogenous across countries,
sexes and age groups, then we will combine studies from all of these
populations into one pooled effect estimate that could be applied across
all combinations of countries, sexes and age groups in the WHO/ILO
joint methodology.
If we judge two or more studies for the relevant combination of
country, sex and age group, or combination thereof, to be sufficiently
clinically homogenous to potentially be combined quantitatively using
quantitative meta-analysis, then we will test the statistical hetero-
geneity of the studies using the I2 statistic (Figueroa, 2014). If two or
more clinically homogenous studies are found to be sufficiently
homogenous statistically to be combined in a meta-analysis, we will
pool the risk ratios of the studies in a quantitative meta-analysis, using
the inverse variance method with a random effects model to account for
cross-study heterogeneity (Figueroa, 2014). The meta-analysis will be
conducted in RevMan 5.3, but the data for entry into these programmes
may be prepared using another recognized statistical analysis pro-
gramme, such as Stata. We will not quantitatively combine data from
studies with different designs (e.g. combining cohort studies with case-
controls studies), nor unadjusted and adjusted models. We will only
combine studies that we judge to have a minimum acceptable level of
adjustment for confounders. If quantitative synthesis is not feasible,
then we will synthesise the study findings narratively and identify the
estimates that we judged to be the highest quality evidence available.
3.2.7. Additional analyses
If we source micro-data on exposure, outcome and potential con-
founding variables, we may conduct meta-regressions to adjust opti-
mally for potential confounders.
If there is evidence for differences in effect estimates by country,
sex, age, industrial sector and/or occupation, or by a combination of
these variables, then we will conduct subgroup analyses by the relevant
variable or combination of variables, as feasible. Where both studies on
workers in the informal economy and studies on workers in the formal
economy are included, we will conduct subgroup analyses by formality
of economy. Findings of these subgroup analyses, if any, will be used as
parameters for estimating burden of disease specifically for relevant
populations defined by these variables. We will also conduct subgroup
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analyses by study design (e.g. randomized controlled trials versus co-
hort studies versus case-control studies).
We will perform a sensitivity analyses that will include only studies
judged to be of “low” or “probably low” risk of bias from conflict of
interest; judged to be of “low” or “probably low” risk of bias; and with
documented or approximated ICD-10 diagnostic codes. We may also
conduct a sensitivity analysis using an alternative meta-analytic model,
namely the inverse variance heterogeneity (IVhet) model (Doi et al.,
2017).
3.2.8. Quality of evidence assessment
We will assess quality of evidence using a modified version of the
Navigation Guide quality of evidence assessment tool (Lam et al.,
2016c). The tool is based on the GRADE approach (Schünemann et al.,
2011) adapted specifically to systematic reviews in occupational and
environmental health (Morgan et al., 2016). Should a more suitable
method become available, we may switch to it.
We (out of: PK, PPFMK, FM, HFVM, SM and SN) will assess quality
of evidence for the entire body of evidence by outcome. We will adopt
or adapt the latest Navigation Guide instructions (Appendix D) for
grading the quality of evidence (Lam et al., 2016c). We will downgrade
the quality of evidence for the following five GRADE reasons: (i) risk of
bias; (ii) inconsistency; (iii) indirectness; (iv) imprecision; and (v)
publication bias. If our systematic review includes ten or more studies,
we will generate a funnel plot to judge concerns on publication bias. If
it includes nine or fewer studies, we will judge the risk of publication
bias qualitatively. To assess risk of bias from selective reporting, pro-
tocols of included studies, if any, will be screened to identify instances
of selective reporting.
We will grade the evidence, using the three Navigation Guide stan-
dard quality of evidence ratings: “high”, “moderate” and “low” (Lam
et al., 2016c). Within each of the relevant domains, we will rate the
concern for the quality of evidence, using the ratings “none”, “serious”
and “very serious”. As per Navigation Guide, we will start at “high” for
randomized studies and “moderate” for observational studies. Quality
will be downgrade for no concern by nil grades (0), for a serious con-
cern by one grade (−1) and for a very serious concern by two grades
(−2). We will up-grade the quality of evidence for the following other
reasons: large effect, dose-response and plausible residual confounding
and bias. For example, if we have a serious concern for risk of bias in a
body of evidence consisting of observational studies (−1), but no other
concerns, and there are no reasons for upgrading, then we will down-
grade its quality of evidence by one grade from “moderate” to “low”.
3.2.9. Strength of evidence assessment
We (out of: PK, PPFMK, FM, HFVM, SM and SN) will apply the
standard Navigation Guide methodology (Lam et al., 2016c) to rate the
strength of the evidence. The rating will be based on a combination of
the following four criteria: (i) quality of the body of evidence; (ii) di-
rection of the effect; (iii) confidence in the effect; and (iv) other com-
pelling attributes of the data that may influence our certainty. The
ratings for strength of evidence for the effect of exposure to occupa-
tional ergonomic risk factors on osteoarthritis, and any other muscu-
loskeletal disease respectively, will be “sufficient evidence of harmful-
ness”, “limited evidence of harmfulness”, “inadequate evidence of
harmfulness” and “evidence of lack of harmfulness” (Appendix I).
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